{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T21:50:30Z","timestamp":1770328230480,"version":"3.49.0"},"reference-count":14,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCEH","J Clin Exp Hematopathol"],"published-print":{"date-parts":[[2024]]},"DOI":"10.3960\/jslrt.24025","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T22:31:42Z","timestamp":1727476302000},"page":"203-207","source":"Crossref","is-referenced-by-count":2,"title":["Insulin-like growth factor II mRNA binding protein 3 is highly                    expressed in primary diffuse large B-cell lymphoma of the CNS"],"prefix":"10.3960","volume":"64","author":[{"given":"Kentaro","family":"Odani","sequence":"first","affiliation":[{"name":"Department of Diagnostic Pathology, Osaka Red Cross Hospital,                            Osaka, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakazu","family":"Fujimoto","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Kyoto University Hospital,                            Kyoto, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotake","family":"Fujii","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Osaka Red Cross Hospital,                            Osaka, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manduwa","family":"Saka","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Kyoto University Hospital,                            Kyoto, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Mizoguchi","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Kyoto University Hospital,                            Kyoto, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Hirata","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Kyoto University Hospital,                            Kyoto, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaki","family":"Sakurai","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Osaka Red Cross Hospital,                            Osaka, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhide","family":"Takeuchi","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Kyoto University Hospital,                            Kyoto, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachiko","family":"Minamiguchi","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Kyoto University Hospital,                            Kyoto, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiki","family":"Arakawa","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Kyoto University Hospital, Kyoto,                            Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironori","family":"Haga","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Kyoto University Hospital,                            Kyoto, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2349","reference":[{"key":"1","unstructured":"1 Deckert M, Ferry JA, Paulus W, <i>et                        al.<\/i> Primary diffuse large B-cell lymphoma of the CNS. In: WHO                    Classification of Tumours Editorial Board (ed): Central Nervous System Tumours.                    WHO Classification of Tumours Series, 5th ed, Volume 6. Lyon, International                    Agency for Research on Cancer. 2021; pp. 351-355."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Air                            EL,                                Leach                            JL,                                Warnick                            RE,                                McPherson                            CM. Comparing                    the risks of frameless stereotactic biopsy in eloquent and noneloquent regions                    of the brain: a retrospective review of 284 cases. J Neurosurg. 2009; 111:                    820-824.","DOI":"10.3171\/2009.3.JNS081695"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Ranheim                            EA. Pearls and                    pitfalls in the diagnostic workup of small lymph node biopsies. Mod Pathol.                    2019; 32: 38-43.","DOI":"10.1038\/s41379-018-0151-2"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Chabaane                            M,                                Amelot                            A,                                Riche                            M                    <i>et al.<\/i> Efficacy of a second brain biopsy for intracranial                    lesions after initial negativity. J Clin Neurol. 2020; 16:                    659-667.","DOI":"10.3988\/jcn.2020.16.4.659"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 King                            RL,                                Pasha                            T,                                Roullet                            MR,                                Zhang                            PJ,                                Bagg                            A. IMP-3 is                    differentially expressed in normal and neoplastic lymphoid tissue. Hum Pathol.                    2009; 40: 1699-1705.","DOI":"10.1016\/j.humpath.2009.05.003"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Odani                            K,                                Fujimoto                            M,                                Hirata                            M                    <i>et al.<\/i> Immunohistochemistry of the oncofetal protein IMP3 is                    helpful in the diagnosis of intravascular large B-cell lymphoma using skin                    biopsy. J Cutan Pathol. 2022; 49: 438-441.","DOI":"10.1111\/cup.14196"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Saka                            M,                                Fujimoto                            M,                                Mizoguchi                            K                    <i>et al.<\/i> Insulin-like growth factor II mRNA-binding protein 3 is                    a highly sensitive marker for intravascular large B-cell lymphoma:                    immunohistochemical analysis of 152 pathology specimens from 88 patients. Am J                    Surg Pathol. 2024; 48: 671-680.","DOI":"10.1097\/PAS.0000000000002214"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Hans                            CP,                                Weisenburger                            DD,                                Greiner                            TC                    <i>et al.<\/i> Confirmation of the molecular classification of diffuse                    large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood.                    2004; 103: 275-282.","DOI":"10.1182\/blood-2003-05-1545"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Wu                            C,                                Ma                            H,                                Qi                            G,                                Chen                            F,                                Chu                            J. Insulin-like                    growth factor II mRNA-binding protein 3 promotes cell proliferation, migration                    and invasion in human glioblastoma. OncoTargets Ther. 2019; 12:                    3661-3670.","DOI":"10.2147\/OTT.S200901"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Bhargava                            S,                                Visvanathan                            A,                                Patil                            V                    <i>et al.<\/i> IGF2 mRNA binding protein 3 (IMP3) promotes glioma cell                    migration by enhancing the translation of RELA\/p65. Oncotarget. 2017; 8:                    40469-40485.","DOI":"10.18632\/oncotarget.17118"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Ferreri                            AJM,                                Calimeri                            T,                                Cwynarski                            K                    <i>et al.<\/i> Primary central nervous system lymphoma. Nat Rev Dis                    Primers. 2023; 9: 29.","DOI":"10.1038\/s41572-023-00439-0"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Deckert                            M,                                Brunn                            A,                                Montesinos-Rongen                            M,                                Terreni                            MR,                                Ponzoni                            M. Primary                    lymphoma of the central nervous system--a diagnostic challenge. Hematol Oncol.                    2014; 32: 57-67.","DOI":"10.1002\/hon.2087"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Hajj-Ali                            RA,                                Calabrese                            LH. Diagnosis                    and classification of central nervous system vasculitis. J Autoimmun. 2014;                    48-49: 149-152.","DOI":"10.1016\/j.jaut.2014.01.007"},{"key":"14","unstructured":"14 Zhang                            X,                                Zhang                            Y,                                Guan                            W                    <i>et al.<\/i> Development of diagnostic recommendations for                    vitreoretinal lymphoma. Ocul Immunol Inflamm. 2023; 1-8."}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/64\/3\/64_24025\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T05:06:02Z","timestamp":1727499962000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/64\/3\/64_24025\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.24025","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"article-number":"24025"}}